Welcome to our dedicated page for Integer Hldgs SEC filings (Ticker: ITGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Device engineers know that building a pacemaker lead is painstaking; reading the filings of the company that makes it can be just as exacting. Integer Holdings’ 10-K spans intricate disclosures on cardiac rhythm management, neuromodulation, and sterile manufacturing lines, creating a maze for anyone hunting key numbers or insider moves. If you have ever typed “Integer Holdings SEC filings explained simply” or wanted the cardiac segment margin without scrolling through 250 pages, you have felt the problem.
Stock Titan delivers the solution. Our platform ingests every submission the moment it hits EDGAR and converts legal jargon into plain language with AI-powered summaries. Want “Integer Holdings quarterly earnings report 10-Q filing” insights? Need “Integer Holdings insider trading Form 4 transactions” in real time? Looking for the specific 8-K that details a new sterilization line? Find them fast, plus concise explanations of why they matter. Key sections are surfaced automatically so you can:
- Track “Integer Holdings executive stock transactions Form 4” before material events
- Compare backlog growth across divisions using “Integer Holdings earnings report filing analysis”
- Spot pay structures in the “Integer Holdings proxy statement executive compensation”
Whether you are understanding Integer Holdings SEC documents with AI for compliance checks or modelling forecasts, every 10-K, 10-Q, 8-K material event, and “Integer Holdings annual report 10-K simplified” summary is here—updated continuously, searchable instantly, and interpreted clearly. Save hours, avoid missed details, and make confident decisions with the only page that links Integer’s precision manufacturing story to the numbers behind it.
Integer Holdings Corporation appointed Payman Khales to its Board and as President and Chief Executive Officer, effective
The company entered into a new Employment Agreement with Mr. Khales on
Integer Holdings (ITGR) filed a 10‑Q/A (Amendment No. 1) for the quarter ended September 26, 2025 to add context to MD&A. The amendment incorporates narrative from the October 23, 2025 earnings call about sales outlook and new product adoption expected to affect the next three fiscal quarters. No changes were made to the financial statements.
For Q3 2025, sales were $467.7 million and income from continuing operations was $39.7 million ($1.11 diluted EPS). Year‑to‑date, sales were $1.382 billion with $54.2 million of income from continuing operations ($1.52 diluted EPS). Cardio & Vascular sales rose 15% in Q3, aided by contributions from the Precision and VSi acquisitions.
Management updated its sales outlook to reflect lower‑than‑anticipated demand from select emerging customers and expects 2026 declines in three new products (two electrophysiology, one neuromodulation). In March 2025, the company issued $1.0 billion of 1.875% 2030 convertible notes (net
Integer Holdings Corporation reported third-quarter 2025 results. Sales were $467.7 million, up from $431.4 million a year ago. Operating income was $56.4 million versus $58.0 million. Net income rose to $39.7 million from $35.4 million, and diluted EPS was $1.11 compared with $0.99.
For the first nine months of 2025, sales reached $1.38 billion versus $1.27 billion. Net income was $54.2 million, down from $87.2 million, reflecting higher non-operating items, including a $46.7 million induced conversion expense recorded in other loss, net. Cash from operations was $140.7 million while investing used $235.3 million and financing provided $105.3 million.
Integer issued $1.0 billion of 2030 Convertible Notes at 1.875% (initial conversion price about $150.96) and exchanged $383.7 million of its 2028 notes for $384.4 million in cash plus 1,553,806 shares. It also purchased $71.0 million of capped calls. Cash was $58.9 million, long‑term debt $1.19 billion, and equity $1.75 billion. Q3 sales included $14.9 million from 2025 acquisitions (Precision Coating and VSi), and year‑to‑date contribution was $42.1 million. Shares outstanding as of October 17, 2025 were 35,038,426.
Integer Holdings Corporation furnished an 8‑K announcing its results for the third quarter ended September 26, 2025. The company issued a press release and updated its earnings conference call slide presentation, which will be referenced during the call and made available on its website.
The materials are furnished under Items 2.02 and 7.01, not filed, with the press release included as Exhibit 99.1.
On 24 July 2025, Integer Holdings Corporation (NYSE: ITGR) filed a Form 8-K to furnish, rather than file, information under Items 2.02 and 7.01.
- Item 2.02 — Results of Operations and Financial Condition: the company issued a press release announcing financial results for the quarter ended 27 June 2025, attached as Exhibit 99.1.
- Item 7.01 — Regulation FD Disclosure: an updated earnings-call slide deck will be available in the Investor Relations section of its website and referenced during the call.
The filing does not contain any quantitative results, guidance, or other financial metrics. All information is expressly furnished and is therefore not subject to Section 18 liability, nor is it incorporated by reference into Securities Act filings unless specifically stated.
Integer Holdings Corporation (ITGR) filed a Form 4 indicating that director Michael J. Coyle received a grant of 1,355 restricted stock units (RSUs) on 07/10/2025. Each RSU converts into one share of common stock and vests in four roughly equal installments on Aug 21 2025, Nov 21 2025, Feb 21 2026, and May 19 2026. The award was recorded at a price of $0, reflecting standard equity compensation rather than an open-market purchase. Following the grant, Coyle directly holds 1,355 ITGR shares. No derivative securities, sales, or additional transactions were reported, suggesting the filing represents routine director compensation rather than a signal of insider sentiment.
FAQ
What is the current stock price of Integer Hldgs (ITGR)?
What is the market cap of Integer Hldgs (ITGR)?
